Predict your next investment

Aegis Sciences Corporation company logo
Corporation
HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research
aegislabs.com

See what CB Insights has to offer

Partners & Customers

6

Service Providers

1

About Aegis Sciences Corporation

Aegis Sciences Corporation is a toxicology laboratory specializing in forensic and healthcare services that provides science-driven testing and consulting for clients, such as professional and amateur sports organizations, distinguished college and university athletic programs, healthcare professionals, Fortune 500 companies, medical examiners, and government agencies throughout the United States.

Aegis Sciences Corporation Headquarter Location

515 Great Circle Road

Nashville, Tennessee, 37228,

United States

800-533-7052

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Aegis Sciences Corporation Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Aegis Sciences Corporation Rank

Latest Aegis Sciences Corporation News

07:40 ET At 7.1% CAGR, Infectious Disease Diagnostics Market Size to hit 47.70 Billion by 2028 Says Brandessence Market Research

Feb 21, 2022

News provided by Share this article Share this article LONDON, Feb. 21, 2022 /PRNewswire/ -- According to Brandessence Market Research, the Infectious Disease Diagnostics Market size reached USD 29.41 Billion in 2021. The Infectious Disease Diagnostics market size is likely to grow at 7.1% CAGR during 2021-2028 to reach 47.70 Billion by 2028 end. Increasing prevalence of infectious diseases, a growing number of funding for research on infectious disease diagnostics, rising demand for point of care diagnostics test as well as an increasing number of medical laboratories for infectious disease diagnostics testing are driving the growth of Global Infectious Disease Diagnostics market. Scope of Infectious Disease Diagnostics Market Covid-19 has shown a positive impact on the growth of the infectious disease diagnostics market. The outbreak of the Covid-19 pandemic has impacted the Covid-19 is an infectious disease caused by the most recently exposed novel coronavirus. Largely unidentified before the outbreak began in Wuhan (China) in December 2019, Covid-19 moved from a regional crisis to a global pandemic in just a matter of a few weeks. The Covid-19 pandemic negatively affected the overall sales of most of the companies but had a positive impact on the infectious disease diagnostics market since of the use of infectious disease diagnostic methods for Covid-19 testing. Infectious Disease Diagnostics Companies Recent Development: News: Roche Launches the First Infectious Disease Tests and Cobas Omni Utility Channel for Use on the Cobas 5800 System in Countries Accepting the CE Mark On December 15th, 2021; Roche announced the launch of the first infectious disease tests on the cobas 5800 System, a new molecular laboratory instrument, in countries accepting the CE mark. These include cobas HIV-1, cobas HBV, cobas HCV, cobas HIV-1/HIV-2 Qualitative, and the cobas omni Utility Channel kit. These launches expand the Roche Molecular portfolio offering by providing standardised performance and efficiencies across low, medium and high volume molecular laboratory testing needs. Aegis Sciences Launched Infectious Disease Testing On October 11th, 2021; Aegis Sciences Corporation expanded its molecular testing capabilities to rapidly identify pathogens in the respiratory and urogenital health spaces. With Aegis Infectious Disease Testing, providers will have access to: Clinically relevant tests for a wide variety of pathogens and condition, diversity in specimen collection options, 24-hour turnaround time, semi-quantitative reporting available where clinically appropriate and clear, reliable, and actionable results. The testing menu includes customizable order options for the most common pathogens that cause respiratory tract infections (RTIs), genital health/sexually transmitted infections (STIs), gastrointestinal infections (GIs) and urinary tract infections (UTIs). On Special Requirement Infectious Disease Diagnostics Market Report is also available for below Regions and Country: North America 2.7  Global Infectious Disease Diagnostics Market: PEST Analysis  2.8  Global Infectious Disease Diagnostics Market: Attractiveness Analysis  2.8.1  Global Infectious Disease Diagnostics Market: Attractiveness Analysis by Product 2.8.2  Global Infectious Disease Diagnostics Market: Attractiveness Analysis by Type of Testing 2.8.3  Global Infectious Disease Diagnostics Market: Attractiveness Analysis by Technology 2.8.4  Global Infectious Disease Diagnostics Market: Attractiveness Analysis by Disease Type 2.8.5  Global Infectious Disease Diagnostics Market: Attractiveness Analysis by End User Chapter 3  Competitive Analysis  3.1.1  Global Infectious Disease Diagnostics Market Revenue (USD Billion), By Players 2018  3.1.2  Global Infectious Disease Diagnostics Market Revenue Share (%), By Players 2018  ……..And More Look at Related Reports: i-Factor: Live Market intelligence platform I-Factor is our guaranteed seal to keep our clients ahead of the competition, always. This knowledge platform delivers real-time updates on key economic indicators, competitive landscape, changing demand, trends, customized regional insights, and more. The platform visualizes key data points to help make decision making agile, trustworthy, and holistic. Register for free trail here @  https://brandessenceresearch.com/i-factor/login/userRegister     Brandessence Market Research & Consulting Pvt ltd. Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Aegis Sciences Corporation Acquisitions

1 Acquisition

Aegis Sciences Corporation acquired 1 company. Their latest acquisition was Diagnovus on January 06, 2015.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/6/2015

Seed / Angel

$99M

Acquired

1

Date

1/6/2015

Investment Stage

Seed / Angel

Companies

Valuation

$99M

Total Funding

Note

Acquired

Sources

1

Aegis Sciences Corporation Partners & Customers

6 Partners and customers

Aegis Sciences Corporation has 6 strategic partners and customers. Aegis Sciences Corporation recently partnered with Walgreens on January 1, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

1/19/2022

Partner

United States

Walgreens Launches COVID-19 Index to Advance Rapid Detection of Omicron and Track Variant Activity by State.

`` Through Walgreens Boots Alliance , Inc. partnership with Aegis Sciences Corporation , we have the ability to provide this interactive tracking tool and inform the development of strategies and resources to help mitigate the spread of COVID-19 , '' said Dr. Kevin Ban , chief medical officer for Walgreens Boots Alliance , Inc. .

1

1/19/2022

Partner

Hong Kong

Subscribe to see more

Subscribe to see more

10

3/16/2021

Client

United States

Subscribe to see more

Subscribe to see more

10

2/11/2021

Partner

United States

Subscribe to see more

Subscribe to see more

10

11/7/2016

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

1/19/2022

1/19/2022

3/16/2021

2/11/2021

11/7/2016

Type

Partner

Partner

Client

Partner

Partner

Business Partner

Country

United States

Hong Kong

United States

United States

United States

News Snippet

Walgreens Launches COVID-19 Index to Advance Rapid Detection of Omicron and Track Variant Activity by State.

`` Through Walgreens Boots Alliance , Inc. partnership with Aegis Sciences Corporation , we have the ability to provide this interactive tracking tool and inform the development of strategies and resources to help mitigate the spread of COVID-19 , '' said Dr. Kevin Ban , chief medical officer for Walgreens Boots Alliance , Inc. .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

Aegis Sciences Corporation Service Providers

1 Service Provider

Aegis Sciences Corporation has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Accounting Firm

Auditor

Service Provider

Associated Rounds

Provider Type

Accounting Firm

Service Type

Auditor

Partnership data by VentureSource

Aegis Sciences Corporation Team

8 Team Members

Aegis Sciences Corporation has 8 team members, including current Chief Executive Officer, Frank Basile.

Name

Work History

Title

Status

Frank Basile

Chief Executive Officer

Current

Beverly Cawthon

Chief Operating Officer

Current

Tim Ryan

Chief Information Officer

Current

Matthew Hardison

Baylor College of Medicine, and University of Alabama at Birmingham

Senior Vice President

Current

Lisa Wooten

Senior Vice President

Current

Name

Frank Basile

Beverly Cawthon

Tim Ryan

Matthew Hardison

Lisa Wooten

Work History

Baylor College of Medicine, and University of Alabama at Birmingham

Title

Chief Executive Officer

Chief Operating Officer

Chief Information Officer

Senior Vice President

Senior Vice President

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.